Wells Fargo & Company Helius Medical Technologies, Inc. Transaction History

Wells Fargo & Company

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$0.14 - $0.25 $1 - $2	8 Added 4.1%	203 $0
Q1 2023 May 12, 2023	BUY	$0.23 - $0.41 $0 - $1	3 Added 1.56%	195 $0
Q4 2022 Feb 13, 2023	BUY	$0.22 - $14.5 $9 - $638	44 Added 29.73%	192 $0
Q3 2022 Nov 14, 2022	BUY	$0.36 - $17.1 $44 - $2,120	124 Added 516.67%	148 $0
Q2 2022 Aug 12, 2022	BUY	$1.14 - $3.48 $3 - $10	3 Added 14.29%	24 $0
Q4 2021 Feb 14, 2022	BUY	$5.12 - $14.5 $40 - $116	8 Added 61.54%	21 $0
Q3 2021 Nov 15, 2021	BUY	$12.9 - $16.83 $12 - $16	1 Added 8.33%	13 $0
Q1 2021 May 13, 2021	BUY	$11.23 - $18.35 $134 - $220	12 New	12 $0

Ticker HSDT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,197,200
Market Cap $12.7M
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.